Articles

Psychotropic Medication Safety in Post-Acute and HCBS Settings: Preventing Chemical Restraint by Default
Psychotropic medications often persist after discharge without review, becoming de facto behavioral controls rather than therapeutic interventions. This article explains how post-acute providers design safeguards that protect rights, reduce adverse effects, and meet regulatory scrutiny across SNF and community-based settings. Read more...
Opioids and Sedatives in Post-Acute Care: Designing Controls That Prevent Overdose, Falls, and Silent Deterioration
Opioids and sedatives remain a leading cause of preventable harm after discharge, particularly when monitoring intensity drops and escalation authority is unclear. This article examines how post-acute providers design day-to-day controls that reduce overdose risk, falls, and avoidable emergency utilization across SNF and home health settings. Read more...
Post-Acute Diabetes Medication Safety: Insulin Intent, Glucose Monitoring, and Hypoglycemia Response
Insulin and diabetes drugs can destabilize quickly after discharge as appetite, activity, steroids, and kidney function change. This article explains how post-acute providers reduce hypoglycemia and hyperglycemia through insulin-intent handoffs, reliable glucose-data routing, rapid response protocols, and escalation workflows that hold up on nights and weekends. Read more...
High-Risk Anticoagulant Management After Discharge: Warfarin and DOAC Controls Across SNF and Home Health
Anticoagulants are a top driver of preventable post-acute harm because monitoring and decision authority fragment across settings. This article sets out practical controls for warfarin and DOAC safety—reconciliation with indication and stop-dates, monitoring ownership that survives weekends, and escalation pathways that produce an auditable trail. Read more...
Renal Dosing and Drug–Drug Interaction Controls After Discharge: Preventing Toxicity in Polypharmacy
Post-acute polypharmacy toxicity is often predictable: renal function changes, interacting meds, and monitoring gaps after discharge. This article shows how SNFs, home health, and HCBS-linked care coordination run practical renal dosing and interaction controls—who checks what, how changes are escalated, and how organizations evidence safe practice. Read more...
Opioids and Sedating Medications After Discharge: Preventing Respiratory Depression, Falls, and Escalation Failures
Opioids, benzodiazepines, gabapentinoids, and sedating psych meds create a predictable post-discharge harm pattern: over-sedation, falls, missed deterioration, and avoidable ED use. This article sets out the practical controls SNFs, home health, and HCBS partners use to manage sedation risk with clear triggers, decision authority, and auditable follow-through. Read more...
High-Risk Antibiotics and Infection Deterioration at Post-Acute Interfaces: Monitoring, Stop-Dates, and Escalation
Antibiotic risk at post-acute interfaces is operational: missing stop-dates, delayed labs, failure to detect deterioration, and unclear escalation authority. This article shows how SNFs, home health, and HCBS-linked teams run reliable antibiotic monitoring workflows, prevent C. difficile and sepsis escalation, and evidence safe practice to payers and surveyors. Read more...
High-Risk Medication Management in Post-Acute Transitions: Controls That Prevent Early Harm
High-risk meds are where post-acute transitions fail fastest: anticoagulants, insulin, opioids, antipsychotics, and antibiotics. This article sets out practical controls that SNFs, home health, and HCBS partners use to prevent discrepancies, missed monitoring, and delay-driven harm—plus how those controls are evidenced for payers and oversight. Read more...